Skip to main content
Caplight Logo









Abiologics

Abiologics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://abiologics.com/

Last Round

VC Round

Jul 23, 2024

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Abiologics is a biotechnology company that develops a platform for designing and synthesizing supranatural biologics, known as Synteins, using generative artificial intelligence and non-standard amino acids.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoveryprotein engineeringbiotechgenerative AIcomputational biologybiologicsAI drug discoveryin silico drug designtherapeutic developmenthigh-throughput synthesisbiotech platformdrug pipelineprotein designpharma partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abiologics Comparables

Compare Abiologics with similar companies based on industry and business-model similarity.

Abiologics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nabla Bio
89%
Accipiter Biosciences
86%
AI Proteins
86%

Abiologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 23, 2024

Abiologics Investors

Notable investors and investment history

Abiologics investors
InvestorRounds
Flagship PioneeringVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 118% MoM, reaching 3.6K.

  • Mar 3, 2026

    Monthly visitors increased 34% MoM.

Abiologics Filings

Explore SEC and related filing metadata, where available.

Abiologics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Abiologics's valuation, stock price, and market status.

Is Abiologics a public or private company?

Abiologics is a private company.

What is the current stock price of Abiologics?

Abiologics is a private company with no public stock price. No recent secondary market data is available.

How much is Abiologics worth (valuation)?

Valuation information for Abiologics is not publicly available.

Can I buy Abiologics stock?

Abiologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Abiologics's last funding round?

Abiologics's most recent funding round was VC Round on July 23, 2024.

Who are the main investors in Abiologics?

Key investors in Abiologics include Flagship Pioneering.

Will Abiologics IPO soon?

No public IPO plans have been announced for Abiologics.

How can I track Abiologics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abiologics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range26
Year Founded2021
Last FundingJul 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?